Drug Pricing Just One Point of Confusion Over New FDA Vouchers
The Commissioner’s National Priority Vouchers aim to offer accelerated pathways to drugs that meet certain criteria, perhaps including a low price-tag. But the policy is vaguely defined and was announced without public input, going against the FDA’s own published practices, experts say.
Drug Pricing Just One Point of Confusion Over New FDA Vouchers Read More »
